Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder
Clinical trial NCT01825837 · COMPLETED
Trial details
- NCT number
- NCT01825837
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-06-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.